Reporting owner · CIK 0001442786

Chan Phillip P.

Visual SEC Form 4 history across 1 companies, 7 transactions and 3 filings.

CEOChief Executive OfficerCytosorbents Corp
Open-market mix
Filings3Form 4 records
Buying$70K1 purchases
Selling$00 sales
Net value$70KBuys minus sells
Companies15 securities
Most recentSep 04, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Jan 25Feb 251Sep 26

Net value flow

Buys minus sells

Jan 25
$0
Feb 25
$0
Sep 26
$70K

Transaction texture

Ownership and ticket size

Average P/S size$70K
Median P/S size$70K
Direct7
Indirect0
Sep 04, 2026buy

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at Cytosorbents Corp on Sep 04, 2026 valued at $70,000.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
CTSOChan Phillip P.
CEO
buy200k$7.00MP09/0909/04
CTSOChan Phillip P.
CEO
O34.1k-$3.86MO02/27/202502/24/2025
CTSOChan Phillip P.
CEO
O34.1k$3.86MO02/27/202502/24/2025
CTSOChan Phillip P.
CEO
other90.8kJ01/23/202501/17/2025
CTSOChan Phillip P.
CEO
other90.8kJ01/23/202501/17/2025
CTSOChan Phillip P.
CEO
exercise90.8k$0X01/23/202501/17/2025
CTSOChan Phillip P.
CEO
exercise90.8k$9.08MX01/23/202501/17/2025

Chan Phillip P. Insider Activity FAQ

SEC Form 4 context

Who is Chan Phillip P.?

Chan Phillip P. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001442786.

Which companies has Chan Phillip P. reported transactions for?

Cytosorbents Corp

When was Chan Phillip P.'s latest insider buy?

buy at Cytosorbents Corp on Sep 04, 2026 valued at $70,000.

When was Chan Phillip P.'s latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.